Composition for veterinary and medical use
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- IRP健康私人有限公司
- Publication Date
- 2006-10-11
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
Background of the invention
[0001] Gastrointestinal ("GI") dysfunction is caused by pathogen invasion, treatment with broad-spectrum antibiotics, improper diet, stressful lifestyle, and other pathogenic factors. This is a common disease with symptoms such as Intestinal Stress Syndrome (IBS), which is present in 20% of American adults. In Canada, IBS is the leading cause of absenteeism in schools and factories, second only to colds. So far, there is no good medicine for IBS and inflammatory bowel disease (IBD). A satisfactory therapeutic composition should meet the following conditions:
[0002] ●Non-toxic and safe to use.
[0003] ● Will not inhibit the probiotics in the internal organs or produce side effects on them.
[0004] ●Preferably has low oral bioavailability (no systemic effect).
[0005] ●No bacterial resistance.
[0006] ●Anti-inflammatory.
[0007] ●Stop diarrhea and inhibit secretion.
[0008] ●Anti-motility.
[0009] ●Enhance immunity.
[0010] ●Neutralize toxins. ...